Table 6. Agreement between specimens’ results obtained in the clinical laboratory and results obtained in this study in the same assay.
| Assay | Total results compared (n) | Discordant resultsa (n) | Equivocal resultsb (n) |
|---|---|---|---|
| Novatec Novalisa ELISA | 2 | 0 | 1 |
| DiaSorin LIAISON CLIA | 73 | 0 | 4 |
| Euroimmun ELISA | 49 | 0 | 4 |
| Immunetics C6 ELISA | 250 | 4 | 2 |
| Viramed ViraStripe IB | 150 | 2 | 14 |
| Euroimmun Euroline IB | 101 | 6 | 0 |
| Trinity Biotech IB | 11 | 2 | 2 |
| Seramun SeraSpot | 88 | 0 | 0 |
| TOTAL | 724 | 14 | 26 |
a Discordant: those results negative by the clinical laboratory but positive in the study, or vice versa.
b Equivocal: those results equivocal in the clinical laboratory and positive or negative in this study or vice versa (positive or negative in the clinical laboratory and equivocal in this study).